KNCV believes in a programmatic and patient/family approach, and in diagnosis and treatment for all. KNCV supports the introduction of new diagnostic tools, TB drugs and regimens and helps to prepare countries and national TB programs for a rapid uptake.

With KNCV’s Right Diagnosis, Right Treatment initiative we aim to accelerate the processes required for adoption, implementation and scale-up of new tools, including policies and approaches, diagnostic and other technologies, and TB drugs – comprehensively and systematically. We do this in the context of the programmatic management of TB for children and adults.

KNCV’s ‘Patient Triage’ approach

At its core is KNCV’s TB Patient Triage Approach. It promotes access to rapid, highly sensitive and specific molecular tests to detect TB and various forms of DR-TB (if present) coupled with new drugs and regimens. It offers early and correct ‘triaging’ of patients to the least toxic, shortest, most appropriate and effective regimen according to individualized rapid patient drug susceptibility test (DST) results.


The concept of right diagnosis right treatment has benefits at all levels

  • Patients

    • Early treatment
    • Lowest side effects
    • Improved quality of live
  • Health systems

    • Less costly treatments
    • Easier to administer
    • Better treatment rates
  • Public health

    • Reduce risk transmissions
    • Reduce DR-TB
    • Revert the TB burden


A world free of tuberculosis


Right diagnosis and right treatment for every TB patient

How KNCV helps

By now KNCV has helped with the successful implementation of new drugs and shorter treatment regimen in 21 countries.